BLAIR LAPOINTE,BRIAN ANDRESEN,DONGSHAN ZHANG,HONGJUN ZHANG,JOHN MACLEAN,KENNETH JAY BARR,NEVILLE ANTHONY,NUNZIO SCIAMMETTA,RICHARD THOMAS BERESIS
申请号：
BR112015003332
公开号：
BR112015003332A2
申请日:
2013.08.14
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
